<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <title>GlaxoSmithKline Donates Cancer Genomics Dataset to Public Information Network | Depth-First</title>
    <link rel="alternate" href="/articles.atom" title="Depth-First" type="application/atom+xml">
    <link rel="stylesheet" href="/css/reset.css">
    <link rel="stylesheet" href="/css/global.css">
    <link rel="shortcut icon" href="/images/favicon.png">
    <link rel="me" href="https://fosstodon.org/@rapodaca">
        <link rel="stylesheet" href="/css/document.css">
    <link rel="stylesheet" href="/css/syntax.css">
    <link rel="stylesheet" href="/css/article.css">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.css">

  </head>
  <body>
    <header>
      <div class="wrapper">
        <div class="site-id"><a href="/">Depth-First</a></div>
        <nav>
          <ul>
            <li><a href="/articles/">Archive</a></li><li><a href="/about/">About</a></li>
          </ul>
        </nav>
      </div>
    </header>
    <main>
      <div class="wrapper">
            <article>
      <header>
        <h1>GlaxoSmithKline Donates Cancer Genomics Dataset to Public Information Network</h1>
        <p class="byline">By Richard L. Apodaca</p>
          <time datetime="2008-06-27T00:00:00.000Z">2008-06-27T00:00:00.000Z</time>
      </header>
      <p>In a move likely to up the ante in the emerging <a href="http://dx.doi.org/10.1038/nrd2131">Open Source Drug Discovery</a> movement, GlaxoSmithKline have <a href="http://us.gsk.com/html/media-news/pressreleases/2008/2008_us_pressrelease_10097.htm">announced</a> the donation of genomic profiling data for over 300 cancer cell lines to the <a href="https://cabig.nci.nih.gov/">National Cancer Institute's cancer Bioinformatics Grid</a> (caBIG).</p>
<p>According to <a href="https://cabig.nci.nih.gov/faqs/index_html">NCI's FAQ</a>, caBIG is "an open-source, open-access information network enabling cancer researchers to share tools, data, applications, and technologies according to agreed-upon standards and identified needs." caBIG is comprised of publicly-available datasets and open source software tools designed to interact with them.</p>
<p>This move has potential significance on a number of levels:</p>
<ul>
<li>Large pharmaceutical companies haven't generally made a habit out of donating their hard-earned raw intellectual property on this scale. For something this far outside the industry norm, nobody wants to go first; GSK's actions have made the practice a little more respectable.</li>
<li>caBIG is simultaneously a publicly-accessible database, a set of open data specifications, and an open source software platform. In other words, it's striving to become an end-to-end solution to the problem of open collaboration in the biological sciences.</li>
<li>Donating raw data directly into an open repository bypasses the established scientific publication model in which data are communicated only as part of a peer-reviewed publication. Should this new publication model continue to gain popularity, it would fundamentally change the way science is conducted.</li>
</ul>
<p>Credit: <a href="http://wwmm.ch.cam.ac.uk/blogs/murrayrust/?p=1165">Peter Murray-Rust</a>, <a href="http://www.earlham.edu/~peters/fos/2008/06/commentary-on-gsk-cancer-data.html">Peter Suber</a>, and <a href="http://blog.wired.com/wiredscience/2008/06/massive-cancer.html">Wired</a>.</p>
    </article>

      </div>
    </main>
    <footer>
      <ul>
        <li>&copy; 2006-2024<li><a href="https://creativecommons.org/licenses/by/2.0/">CC-BY</a></li><li><a href="/about/">Richard L. Apodaca</a></li><li><a href="/articles.atom">Feed</a></li>
      </ul>
    </footer>
    <script src="/js/moment.js"></script>
    <script src="/js/timestamps.js"></script>
    <script src="/js/analytics.js"></script>
  </body>
</html>